PARP4 and melanoma: Consistent with these studies, our study also demonstrated that PARP4 was linked with poorer prognosis in melanoma and the PARP4 knockdown significantly increased CDDP-induced cell apoptosis, suggesting that PARP4 may play a pivotal role in the occurrence, progression, and treatment of melanoma.